[1]Locationinpatent:schemeortableScheiper,Bodo;Matter,Hans;Steinhagen,Henning;Böcskei,Zsolt;Fleury,Valérie;McCort,Gary[BioorganicandMedicinalChemistryLetters,2011,vol.21,#18,p.5480-5486]
1179359-55-7
1000576-83-9
1000796-62-2
1000931-58-7
1018443-32-7
1169762-18-8
113520-43-7 | 3-Aminomethyl-phenylacetic acid | AA0008SV | MFCD08275113
1138-72-3 | Thiourea, N-(4-methoxyphenyl)-N'-2-propen-1-yl- | AA0009NJ | MFCD00244797
114078-88-5 | 5-bromo-1,2,3-triazine | AA000AFN | MFCD13193660
1143525-35-2 | 1-Cbz-3-methylazetidine-3-carboxylic acid | AA000B1X | MFCD17168405
1160573-72-7 | 1-Bromo-2,5-dichloro-4-iodobenzene | AA000BEY | MFCD11845993
116228-41-2 | 4-Bromo-1-[(4-methylbenzene)sulfonyl]pyrazole | AA000BWH | MFCD06080375
116492-97-8 | 3,3-Bis(methylthio)-2-(3-(trifluoromethyl)benzoyl)acrylonitrile | AA000CJX | MFCD00174303
116710-50-0 | 5-((Benzo[d]thiazol-2-ylthio)methyl)-4-phenyl-4H-1,2,4-triazole-3-thiol | AA000D2R | MFCD03480240
117-57-7 | 3-Hydroxy-2-methyl-4-quinolinecarboxylic acid | AA000DFR | MFCD00044850
1171697-10-1 | (4-Bromothiophen-2-yl)methanamine, HCl | AA000DR1 | MFCD09878584
